Paraoxonase 1 activities and polymorphisms in autism spectrum disorders
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Autism spectrum disorders (ASD) comprise a complex and heterogeneous group of conditions of unknown aetiology, characterized by significant disturbances in social, communicative and behavioural functioning. Recent studies suggested a possible implication of the high‐density lipoprotein associated esterase/lactonase paraoxonase 1 (PON1) in ASD. In the present study, we aimed at investigating the PON1 status in a group of 50 children with ASD as compared to healthy age and sex matched control participants. We evaluated PON1 bioavailability (i.e.arylesterase activity) and catalytic activity (i.e.paraoxonase activity) in plasma using spectrophotometric methods and the two common polymorphisms in the PON1 coding region (Q192R, L55M) by employing Light Cycler real‐time PCR. We found that both PON1 arylesterase and PON1 paraoxonase activities were decreased in autistic patients (respectively,P< 0.001,P< 0.05), but no association with less active variants of the PON1 gene was found. The PON1 phenotype, inferred from the two‐dimensional enzyme analysis, had a similar distribution in the ASD group and the control group. In conclusion, both the bioavailability and the catalytic activity of PON1 are impaired in ASD, despite no association with the Q192R and L55M polymorphisms in the PON1 gene and a normal distribution of the PON1 phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On measures of gametic disequilibrium.
Lewontin, R. C. (1988) · Genetics · doi:10.1093/genetics/120.3.849 · Cited by 712
Chauhan, A., & Chauhan, V. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.007 · Cited by 656
Searching for ways out of the autism maze: genetic, epigenetic and environmental clues
Persico, A. M., & Bourgeron, T. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.05.010 · Cited by 575
Genetic Heterogeneity Between the Three Components of the Autism Spectrum: A Twin Study
RONALD, A., HAPPÉ, F., BOLTON, P., BUTCHER, L. M., PRICE, T. S., WHEELWRIGHT, S., BARON-COHEN, S., & PLOMIN, R. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000215325.13058.9d · Cited by 508 · cited 1×
“Second, we did not obtain more accurate clinical phenotypic descriptions in order to balance our patient group for the heterogeneity of ASD [62].”
MethodEpigenetics of autism spectrum disorders
Schanen, N. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl213 · Cited by 341
How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis
Deth, R., Muratore, C., Benzecry, J., Power-Charnitsky, V.-A., & Waly, M. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2007.09.010 · Cited by 325 · cited 1×
“superoxide dismutase, glutathione peroxidase, catalase), increased lipid peroxidation, disturbances in transsulfuration and altered glutathione levels [47–49].”
BackgroundEvidence of Toxicity, Oxidative Stress, and Neuronal Insult in Autism
Kern, J. K., & Jones, A. M. (2006) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400600882079 · Cited by 265
Engel, S. M., Berkowitz, G. S., Barr, D. B., Teitelbaum, S. L., Siskind, J., Meisel, S. J., Wetmur, J. G., & Wolff, M. S. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm029 · Cited by 260 · cited 1×
“Taking maternal PON1 status into consideration greatly increases the risk for this adverse behaviour [6].”
BackgroundJyonouchi, H., Sun, S., & Itokazu, N. (2002) · Neuropsychobiology · doi:10.1159/000065416 · Cited by 225
Autistic disorder and gastrointestinal disease
Horvath, K., & Perman, J. A. (2002) · Current Opinion in Pediatrics · doi:10.1097/00008480-200210000-00004 · Cited by 224 · cited 4×
“Rozenberg O, Aviram M. SGlutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity.”
BackgroundInfluential
Cited by
Environmental toxicants and autism spectrum disorders: a systematic review
Rossignol, D. A., Genuis, S. J., & Frye, R. E. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.4 · Cited by 458
Herbert, M. R. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328336a01f · Cited by 356
Mitochondrial dysfunction in autism spectrum disorders: Cause or effect?
Palmieri, L., & Persico, A. M. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.04.018 · Cited by 173
Eskenazi, B., Huen, K., Marks, A., Harley, K. G., Bradman, A., Barr, D. B., & Holland, N. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.1002234 · Cited by 133
“In line with these results, Pasca et al. (2010) reported that ARYase levels and POase activity were significantly lower in 50 Romanian autistic children compared with 30 age- and sex-matched nonautistic controls, but they observed no differences in PON1192 or PON155 allelic frequencies between…”
BackgroundResultDecreased serum arylesterase activity in autism spectrum disorders
Gaita, L., Manzi, B., Sacco, R., Lintas, C., Altieri, L., Lombardi, F., Pawlowski, T. L., Redman, M., Craig, D. W., Huentelman, M. J., et al. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.04.010 · Cited by 39
Metadata
- Authors
- Paşca, S. P., Dronca, E., Nemeş, B., Kaucsár, T., Endreffy, E., Iftene, F., Benga, I., Cornean, R., & Dronca, M.
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2010-03
- Volume
- 14
- Issue
- 3
- Pages
- 600-607
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- OpenAlex
- W1978819778
- Cited by
- 28
- References
- 12
- FWCI
- 0.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Paraoxonase 1 activities and polymorphisms in autism spectrum disorders. https://app.cochat.ai/papers/10.1111/j.1582-4934.2008.00414.x
- The paper
- Paşca, S. P., Dronca, E., Nemeş, B., Kaucsár, T., Endreffy, E., Iftene, F., Benga, I., Cornean, R., & Dronca, M. (2010). Paraoxonase 1 activities and polymorphisms in autism spectrum disorders. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2008.00414.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.